Optimizerx Corp OPRX

$6.70 -0.31 (-4.42%)

Valuation

Market cap
132,538,000
Revenue TTM
$109,430,000
Net income TTM
$5,130,000
P/E (trailing)
11.25
P/E (forward)
14.92
Profit margin
4.69%
Debt to equity
0.10

Trading

Volume
186,700
Avg volume
202,308
Day's range
$6.57 – $7.10
Shares out
18,907,000
Stochastic %K
11%
Beta
1.20
Analysts
Strong Buy
Price target
$12.10

Price

Company profile

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand mes...

Show more

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Industry
Health Information Services
Sector
Healthcare
Phone
248 651 6568
Website
https://www.optimizerx.com
Address
260 Charles Street, Suite 302, Waltham, United States

Latest news

Stocktwits

eWhispers Nov 16, 3:46 PM
FactSet has updated its numbers for the latest earnings season, but its analysis misses a critical point: earnings estimates are not the same as earnings expectations. https://advantage.factset.com/hubfs/Website/Resources%20Section/Research%20Desk/Earnings%20Insight/EarningsInsight_111326.pdf And the market's reaction to earnings surprises makes that distinction pretty clear. 132 companies BEAT consensus but MISSED the Earnings Whisper. Their stocks fell an average of 1.5%, with just 43% trading higher. But here's the more revealing part: Companies that MISSED consensus but BEAT the Earnings Whisper saw their stocks gain an average of 1.7%, and roughly two-thirds traded higher, despite supposedly missing earnings expectations! In other words, the market treated many reported earnings beats like misses, while rewarding companies that supposedly missed estimates. And companies that beat both consensus and the Earnings Whisper gained an average of 2.7% — more than double the 1.1% gain FactSet reports for companies beating consensus estimates. If consensus estimates are the expectations that matter, why are companies missing those estimates but beating the Earnings Whisper more likely to trade higher than companies doing the opposite? The market responds to more than earnings per share, but these results suggest the Earnings Whisper is capturing something consensus estimates are missing. There's a difference between beating the estimate and beating expectations. And the market appears to know it. So why would you continue relying on consensus estimates to determine whether a company beat or missed earnings expectations? https://www.earningswhispers.com/investors-sign-up?a=smQ3 $RDDT $HLIO $FTNT $BROS $OPRX
1 replies
focafoca99 Nov 16, 12:55 PM
$OPRX expects management to attend the 15th Annual ROTH Technology Conference on Nov 18 in New York.
0 replies
MikeyMcDermott Nov 11, 11:33 PM
$OPRX naw they sold the calls!! Wow!!
0 replies
EarningsInsider Nov 11, 10:31 PM
https://www.marketbeat.com/earnings/reports/2026-11-11-optimizerx-co-stock/ $OPRX OptimizeRx Earnings Transcript
0 replies
StocktwitsEarnings Nov 11, 10:26 PM
$OPRX Q3 '26 Earnings Results & Recap OptimizeRx updated fiscal year 2026 guidance to revenue of $87M to $93M and adjusted EBITDA of $21M to $25M; adjusted EBITDA guidance was unchanged.
0 replies
RazorbackAJ Nov 11, 9:32 PM
$OPRX Complete disaster from Optimize RX - shorting here and could see a 50% haircut tomorrow. Current trailing stop at $9.25. Follow for setups like this — exact entries, precise stop levels, nothing vague. This is how I trade, not financial advice.
0 replies
MikeyMcDermott Nov 11, 7:25 PM
$OPRX they are buying the 7.50 calls today. This thing probably going 12+
0 replies
Shayah Oct 21, 6:10 PM
$OPRX with a textbook technical expansion today. That multi-week consolidation under the $9.05 pivot finally broke, printing an intraday high of $9.60 (+5.4%). The key now into the close is converting prior supply at $9.05 into a structural demand shelf. If $9.05 holds on backtests, the path of least resistance clears toward the next liquidity pocket at $10.50–$11.00
0 replies